ARTICLE | Financial News
Achillion files for IPO
April 4, 2006 12:25 AM UTC
Infectious disease company Achillion (New Haven, Conn.) filed to raise up to $75 million in an IPO underwritten by Cowen; CIBC; and JMP. The company's lead compound is elvucitabine, a nucleoside rever...